Back to search

Article

COL22A1 and DNAH8 mutations are associated with tumor mutation burden and prognosis of lung adenocarcinoma patients

2022-10-19

Abstract excerpt

<title>Abstract</title> <p>Lung cancer is one of the leading causes of death in patients with tumor around the world. Lung adenocarcinoma (LUAD) is most frequent histological subtype in lung cancer. Immune therapy has now become an effective method of treating LUAD. Tumor mutation burden (TMB) shows predictive biomarker potential for identification of cancer patients responding to immune checkpoint inhibitors. Th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8460bf84-dd93-5e6d-9b0b-5fe4effa2c37
DOI
10.21203/rs.3.rs-2162636/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
COL22A1 and DNAH8 mutations are associated with tumor mutation burden and prognosis of lung adenocarcinoma patientsDOI 10.21203/rs.3.rs-2162636/v1
Exploration of Tumor Mutation Burden Combined with Immune Infiltrates in the Prognosis of Lung AdenocarcinomaSemantic proximity
Association Between Tumor Mutation Burden (TMB) and immune microenvironment in lung squamous cell carcinomaSemantic proximity
Clinical Relevance of Somatic Mutations in Chinese Lung Adenocarcinoma and Their Prognostic Implications for SurvivalSemantic proximity
Identification of hub-methylated differentially expressed genes in lung adenocarcinoma and immunotherapy resistanceSemantic proximity
Comprehensive pan-cancer analysis identifies H2AFX associated with poor prognosis in lung adenocarcinomaSemantic proximity
Genetic and tumor microenvironment differences between cell cycle progression pathway altered/non-altered patients with lung adenocarcinomaSemantic proximity
Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival.Semantic proximity
Up-regulated tumor intrinsic growth potential and decreased immune function orchestrate the evolution of lung adenocarcinomaSemantic proximity
PCDH11X mutation as a potential biomarker for immune checkpoint therapies in lung adenocarcinoma.Semantic proximity
Titin Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell CarcinomaSemantic proximity
DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung CancerSemantic proximity
Upregulation of Ferroptosis-Related Fanconi Anemia Group D2 is a Poor Prognostic Factor and Indicator of Tumor Immune Cell Infiltration in Lung AdenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.